| SHFS 0.0231 45.28% | RCT 0.0348 13.36% | INLF 0.5296 -2.83% | SCKT 0.438 74.43% | SOXL 68.7118 22.57% | NVDA 176.12 4.28% | AUUD 0.2873 19.61% | LICN 0.0389 -6.83% | CRWV 61.3042 25.80% | BDMD 0.1115 14.95% | HUHU 0.3 -24.62% | SOXS 42.72 -22.83% | NXXT 2.45 1,213.67% | INTC 63.6817 9.55% | SPCX 143.47 0.27% | NCT 0.8297 102.91% | ARAI 0.0532 0.00% | CHSN 0.8303 -64.67% | IREN 21.2629 7.77% | MI 0.4952 21.82% | SPDN 8.545 -1.33% | TQQQ 61.247 8.29% | NVD 5.71 -8.35% | KORU 8.8499 22.74% | YFOR 0.0468 -17.89% | PARA 0.071 -8.97% | NOK 8.535 3.45% | SOXX 157.7 7.58% | BITO 9.865 0.77% | NVDL 20.915 8.48% | RWM 14.1846 -0.77% | SQQQ 39.9371 -8.32% | HUBC 0.0745 -1.97% | MUU 19.19 27.09% | CRWG 7.205 50.42% | CIFR 7.175 9.88% | YMAT 1.2601 26.01% | YMT 1.0444 300.46% | GEVO 1.835 32.01% | UCL 0.2284 20.85% | GRAB 3.37 0.60% | AMD 555.765 7.87% | DVLT 0.0574 -2.05% | WULF 13.4946 7.44% | SMCI 30.8935 11.17% | KWEB 23.755 -1.27% | TSLG 5.2501 6.49% | TSLL 10.53 6.90% | STLA 4.125 -3.17% | IBIT 41.98 0.72%

IQVIA: 3 Key Takeaways for Long-Term Investors

Net new clinical bookings reached $3.2 billion in the third quarter. Last 12-month net new bookings increased 14% to $11.7 billion.

TC Trade Conquest Newsroom November 9, 2026 ·1 min read

IQVIA: 3 Key Takeaways for Long-Term Investors

Key takeaways

Margin expansion despite cost headwinds reveals how operational discipline is fueling profitability gains.
On its third-quarter 2026 earnings call, held on Oct. 27, 2026, IQVIA (IQV) reported accelerating revenue growth and raised full-year financial guidance.
Contract research providers rely on multiyear booking trends to signal long-term revenue direction.

Net new clinical bookings reached $3.2 billion in the third quarter. Last 12-month net new bookings increased 14% to $11.7 billion.

See the latest quote, chart and news for IQV.

Read the full story at fool.com ↗

Want trade ideas like this in real time? Subscribe to Trade Conquest.

More news